NULOJIX

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0003-0371
  • Package NDC 0003-0371-13
  • Application number BLA125288
  • SPL ID 9057087d-7e59-4e5a-8e4a-96a532efb0ab
  • SPL set ID c16ac648-d5d2-9f7d-8637-e2328572754e
  • UNII E3B2GI648A
  • RxCUI 1112976
  • RxCUI 1112980

What the source publishes

Labeler
E.R. Squibb & Sons, L.L.C.
Active ingredients
BELATACEPT
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab
{
  "name": "NULOJIX",
  "splId": "9057087d-7e59-4e5a-8e4a-96a532efb0ab",
  "labels": [
    {
      "setId": "c16ac648-d5d2-9f7d-8637-e2328572754e",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c16ac648-d5d2-9f7d-8637-e2328572754e",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c16ac648-d5d2-9f7d-8637-e2328572754e"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "E.R. Squibb & Sons, L.L.C.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-0371-13)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE",
      "package_ndc": "0003-0371-13",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20110615"
    }
  ],
  "productId": "0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "0003-0371",
  "deaSchedule": null,
  "genericName": "BELATACEPT",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BELATACEPT",
      "strength": "250 mg/1"
    }
  ],
  "applicationNumber": "BLA125288",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20110615",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000182829",
      "N0000182830",
      "N0000182150",
      "N0000182151"
    ],
    "unii": [
      "E3B2GI648A"
    ],
    "rxcui": [
      "1112976",
      "1112980"
    ],
    "spl_set_id": [
      "c16ac648-d5d2-9f7d-8637-e2328572754e"
    ],
    "pharm_class_pe": [
      "T Lymphocyte Costimulation Activity Blockade [PE]"
    ],
    "pharm_class_epc": [
      "Selective T Cell Costimulation Blocker [EPC]"
    ],
    "pharm_class_moa": [
      "CD80-directed Antibody Interactions [MoA]",
      "CD86-directed Antibody Interactions [MoA]"
    ],
    "manufacturer_name": [
      "E.R. Squibb & Sons, L.L.C."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab"